Literature DB >> 7683343

In vitro invasive potential and type IV collagenolytic activity of human renal cell carcinoma cells derived from primary and metastatic lesions.

N Otani1, T Tsukamoto, I Saiki, J Yoneda, T Mitaka, Y Kumamoto.   

Abstract

We investigated in vitro invasiveness and type IV collagenolytic activity of cells from a primary and a metastatic lesion of a patient with renal cell carcinoma. The temporarily cultured cells (SRCC-1P) derived from the primary lesion and those (SRCC-1M) from the metastatic lesion exhibited positive staining for both cytokeratin and vimentin, indicating that they were of renal cell carcinoma origin. An in vitro invasion assay revealed that the cells of SRCC-1M were significantly more invasive than those of SRCC-1P, which showed only marginal invasion. Type IV collagenolytic activity correlated with the in vitro invasiveness, in which SRCC-1M apparently had the higher activity. These results indicate that type IV collagenolytic activity contributes to the invasiveness of the cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683343     DOI: 10.1016/s0022-5347(17)36343-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Authors:  S Koochekpour; M Jeffers; P H Wang; C Gong; G A Taylor; L M Roessler; R Stearman; J R Vasselli; W G Stetler-Stevenson; W G Kaelin; W M Linehan; R D Klausner; J R Gnarra; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Effect of IL-6 on tumor cell invasion of vascular endothelial monolayers.

Authors:  Y Kitamura; I Morita; Z Nihei; Y Mishima; S Murota
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study.

Authors:  Senem Maral; Muradiye Acar; Ozlem Sahin Balcik; Eyyup Uctepe; Omer Faruk Hatipoglu; Derya Akdeniz; Hatice Uludag Altun; Ali Kosar; Mehmet Gunduz; Esra Gunduz
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.